SVA [SINOVAC BIOTECH] 6-K: (Original Filing)
[Sinovac Reports Unaudited First Half of 2018 Financial Results BEIJING, China, November 8, 2018 /PRNewswire/ -- Sinovac Biotech Ltd. (NASDAQ: SVA) (“Sinovac” or the “Company”), a leading provider of biopharmaceutical products in China, announced today its unaudited financial results for the six mont]